Bill Snyder Archive — Page 68 of 119
-
January 12, 2018
BOLD view of white matter
Vanderbilt investigators have discovered that functional MRI detects neural activity in both gray and white matter in the brain, suggesting new ways to investigate diseases such as Alzheimer’s and multiple sclerosis. -
January 11, 2018
VUMC joins national effort to block global pandemics of potentially lethal viruses
The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika. -
January 8, 2018
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia. -
January 4, 2018
Research sheds light on how microtubules are assembled
Microtubules are the “railroad tracks” essential for moving intracellular “freight” around in the cell. They’re also part of the spindle that pulls the two centrosomes apart during cell division. -
December 15, 2017
The toll of dysphagia
Impaired swallowing — dysphagia — affects 3 percent of hospital inpatients, who have longer hospital stays and are more likely to require post-acute care services. -
December 14, 2017
Crowe elected a fellow of the National Academy of Inventors
James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center (VUMC), has been named a fellow of the National Academy of Inventors (NAI).